Mexico grants emergency use approval for Merck's COVID-19 pill

Mexico's health regulator has granted authorization for emergency use of drugmaker Merck's COVID-19 pill Molnupiravir, President Andres Manuel Lopez Obrador said on Friday. The health regulator, COFEPRIS, confirmed the approval in a statement later in the day. COFEPRIS was expected to soon also approve Pfizer's Paxlovid pill to treat COVID-19, Lopez Obrador added at a regular news conference.

Mexico's health regulator has granted authorization for emergency use of drugmaker Merck's COVID-19 pill Molnupiravir, President Andres Manuel Lopez Obrador said on Friday.

The health regulator, COFEPRIS, confirmed the approval in a statement later in the day. COFEPRIS was expected to soon also approve Pfizer's Paxlovid pill to treat COVID-19, Lopez Obrador added at a regular news conference. Both medications were approved last month https://www.reuters.com/world/us/us-fda-authorizes-mercks-at-home-antiviral-covid-19-pill-2021-12-23 in the United States.

Molnupiravir was developed with Ridgeback Biotherapeutics and shown to reduce hospitalizations and deaths by around 30% in a clinical trial of high-risk individuals early in the course of the illness. Lopez Obrador said he planned to make both medications available in public hospitals.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)